Correlation Between LeMaitre Vascular and Harvard Bioscience

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both LeMaitre Vascular and Harvard Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining LeMaitre Vascular and Harvard Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between LeMaitre Vascular and Harvard Bioscience, you can compare the effects of market volatilities on LeMaitre Vascular and Harvard Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in LeMaitre Vascular with a short position of Harvard Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of LeMaitre Vascular and Harvard Bioscience.

Diversification Opportunities for LeMaitre Vascular and Harvard Bioscience

-0.6
  Correlation Coefficient

Excellent diversification

The 3 months correlation between LeMaitre and Harvard is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding LeMaitre Vascular and Harvard Bioscience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Harvard Bioscience and LeMaitre Vascular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on LeMaitre Vascular are associated (or correlated) with Harvard Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Harvard Bioscience has no effect on the direction of LeMaitre Vascular i.e., LeMaitre Vascular and Harvard Bioscience go up and down completely randomly.

Pair Corralation between LeMaitre Vascular and Harvard Bioscience

Given the investment horizon of 90 days LeMaitre Vascular is expected to generate 0.23 times more return on investment than Harvard Bioscience. However, LeMaitre Vascular is 4.36 times less risky than Harvard Bioscience. It trades about 0.39 of its potential returns per unit of risk. Harvard Bioscience is currently generating about -0.03 per unit of risk. If you would invest  9,473  in LeMaitre Vascular on September 2, 2024 and sell it today you would earn a total of  1,226  from holding LeMaitre Vascular or generate 12.94% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

LeMaitre Vascular  vs.  Harvard Bioscience

 Performance 
       Timeline  
LeMaitre Vascular 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in LeMaitre Vascular are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, LeMaitre Vascular unveiled solid returns over the last few months and may actually be approaching a breakup point.
Harvard Bioscience 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Harvard Bioscience has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

LeMaitre Vascular and Harvard Bioscience Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with LeMaitre Vascular and Harvard Bioscience

The main advantage of trading using opposite LeMaitre Vascular and Harvard Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if LeMaitre Vascular position performs unexpectedly, Harvard Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Harvard Bioscience will offset losses from the drop in Harvard Bioscience's long position.
The idea behind LeMaitre Vascular and Harvard Bioscience pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas